Skip to main content

Table 6 Thromboembolic events in patients with Gastric cancer

From: Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!

Clinical Variables

Number of Patients

Thromboembolic Events

p-Value

 

(n)

(%)

Chemotherapy Regimen

 ECF

26

8

30.8

0.5982

 Cisplatin-Docetaxel-5FU

137

28

20.4

 Cisplatin-5FU

20

4

20

 Others

8

0

0

Disease Stage

 Early Stage

35

11

31.4

0.0916

 Metastatic

156

29

18.5

Khorana Risk Score

 Lowa

1

1

 

0.5331

 Intermediate

101

19

18.8

 High

89

20

22.5

Age (years)

 Missed

1

  

0.8647

  < 50

90

18

18.5

  ≥ 50

100

21

23.5

  1. ECF Epirubicin, Cisplatin and 5-Flurouracil, 5-FU 5-Flurouracil
  2. a Only one patient and had thrombosis